Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$14.75 -0.28 (-1.86%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Accounts Payables (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) posted Accounts Payables of $39 million for Q2 2026, up 13.9% from $34.24 million a year earlier but down 7.1% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Accounts Payables (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical's Accounts Payables came in at $31 million, down 20.5% from FY2024.

  • Annual Accounts Payables has declined for three consecutive years, though with a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • In prior years, Ultragenyx Pharmaceutical's Accounts Payables was $39 million in FY2024 (-7.4%), $42.11 million in FY2023 (-2.7%), $43.27 million in FY2022 (+152.5%) and $17.14 million in FY2021 (+32.6%).
  • Quarterly Accounts Payables has run from a low of $15.58 million in Q3 2021 to a high of $59.81 million in Q2 2024 over five years.
  • On a year-over-year basis, Accounts Payables increased in four of the last eight quarters, with an average decline of 4.0%.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q4 2022, with growth of 152.5%; the weakest was Q2 2025, with a decline of 42.7%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $42 million (Q1 2026), $31 million (Q4 2025) and $40.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn 39.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.00 Mn
Mar 31, 2026 42.00 Mn
Dec 31, 2025 31.00 Mn
Sep 30, 2025 40.57 Mn
Jun 30, 2025 34.24 Mn
Mar 31, 2025 47.45 Mn
Dec 31, 2024 39.00 Mn
Sep 30, 2024 35.99 Mn
Jun 30, 2024 59.81 Mn
Mar 31, 2024 40.97 Mn
Dec 31, 2023 42.11 Mn
Sep 30, 2023 33.36 Mn
Jun 30, 2023 42.12 Mn
Mar 31, 2023 58.98 Mn
Dec 31, 2022 43.27 Mn
Sep 30, 2022 23.53 Mn
Jun 30, 2022 34.21 Mn
Mar 31, 2022 23.69 Mn
Dec 31, 2021 17.14 Mn
Sep 30, 2021 15.58 Mn
API Access

Ultragenyx Pharmaceutical Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RARE&period=max&api_key=YOUR_API_KEY